New pill shows promise in taming stubborn hives
NCT ID NCT07408219
First seen Feb 19, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study looks at how well the drug remibrutinib works for people with chronic spontaneous urticaria (long-term hives with no clear cause). Researchers will survey 350 patients in the U.S. to see if the drug improves symptom control and quality of life. The goal is to understand how effective the treatment is in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis
RECRUITINGEast Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.